Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Tecentriq (Atezolizumab) is a monoclonal antibody designed to interfere with the PD-L1 protein. By blocking PD-L1, Tecentriq helps to activate T cells, which can then identify and kill cancer cells. Atezolizumab has been shown to be effective in slowing the growth of cancer cells and is often used when other treatments have failed to yield satisfactory results.
Before you buy Tecentriq, it is crucial that you talk to your healthcare provider about potential side effects and Tecentriq cost.
| Fact Table | |
|---|---|
| Formula | Not applicable (biologic) |
| License | FDA approved |
| Bioavailability | Intravenous infusion |
| Legal status | Prescription Drug |
| Chemical Name | Atezolizumab |
| Elimination half-life | Approximately 27 days |
| Dosage (Strength) | 840 mg or 1200 mg via intravenous infusion |
| Pregnancy | Not recommended; potential risk to the fetus |
| Brands | Tecentriq |
| Protein binding | High affinity |
| PubChem CID | 249785152 |
| MedlinePlus | Atezolizumab |
| ChEBI | Not applicable |
| ATC code | L01XC32 |
| DrugBank | DB11595 |
| KEGG | D10703 |
| Routes of administration | Intravenous |
Tecentriq is administered intravenously. The infusion should be given over 60 minutes every 3 weeks until disease progression or unacceptable toxicity. The typical dose of Tecentriq for an adult is 1200 mg administered intravenously every three weeks. However, the dosage can vary based on the specific condition being treated and the patient's medical history. It is crucial that Tecentriq is administered under the supervision of a qualified healthcare professional.
Tecentriq 1200 mg uses atezolizumab as its active ingredient.
Before starting treatment with Tecentriq, it is important to discuss your full medical history with your healthcare provider. Caution is advised in patients with:
Patients should be monitored for infusion-related reactions. Tecentriq should be temporarily or permanently discontinued depending on the severity and onset of these reactions.
Tecentriq can interact with immunosuppressive drugs and certain vaccines. Patients should inform their healthcare providers of all the medications they are taking, including over-the-counter drugs, prescribed medications, and herbal supplements.
Like all medications, Tecentriq can cause side effects, although not everyone experiences them. Common side effects include:
What is Tecentriq?
Tecentriq (atezolizumab) is an immunotherapy drug used to treat certain types of cancer, including non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma.
How effective is Tecentriq?
The effectiveness of Tecentriq depends on the type of cancer it’s treating, the stage of the cancer, and the individual’s overall health.
How does Tecentriq work?
Tecentriq works by targeting a specific protein called programmed death-ligand 1 (PD-L1) that some cancer cells have. By blocking PD-L1, Tecentriq helps the immune system recognize and attack cancer cells.
How is Tecentriq administered?
Tecentriq is given as an intravenous (IV) infusion, usually once every 2, 3, or 4 weeks.
How long do Tecentriq side effects last?
Mild side effects of Tecentriq usually go away on their own after a few days or hours. However, some side effects, such as liver problems, may not be reversible and may persist.
How long do you take Tecentriq?
The duration of Tecentriq treatment is decided between you and your doctor. If Tecentriq is safe and effective for you, you’ll likely take it long term.
How long does it take for Tecentriq to work?
Tecentriq starts to work with your immune system to help fight off cancer when you start receiving the medication.
How long does Tecentriq stay in your system?
The exact duration Tecentriq stays in your system is not specified in the available resources.
Is Tecentriq chemotherapy or immunotherapy?
Tecentriq is an immunotherapy, not chemotherapy. It works with your immune system to fight off cancer.
